The efficacy of Duct tape versus placebo in the treatment of verruca vulgaris (warts) in primary school children
| ISRCTN | ISRCTN53967397 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN53967397 |
| Protocol serial number | NTR466 |
| Sponsor | Care and Public Health Research Institute (CAPHRI) (The Netherlands) |
| Funder | Care and Public Health Research Institute (CAPHRI) (The Netherlands) |
- Submission date
- 27/01/2006
- Registration date
- 27/01/2006
- Last edited
- 23/10/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr M.G. Spigt
Scientific
Scientific
University Maastricht
Department of General Practice
Research Institute CAPHRI
P.O. Box 616
Maastricht
6200 MD
Netherlands
| Phone | +31 (0)43 3882309 |
|---|---|
| m.spigt@hag.unimaas.nl |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised single blind, placebo controlled, parallel group trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Duct tape has a higher efficacy in comparison with a placebo in the treatment of verruca vulgaris. |
| Ethics approval(s) | Received from the local medical ethics committee |
| Health condition(s) or problem(s) studied | Warts (verruca vulgaris) |
| Intervention | 1. Duct tape stuck on the wart for seven days a week and one night a week, for the period of six weeks 2. Placebo (a protection ring for clavi) stuck around the wart one night a week, for the period of six weeks |
| Intervention type | Other |
| Primary outcome measure(s) |
Disappearance of the treated wart |
| Key secondary outcome measure(s) |
1. Disappearance of other warts |
| Completion date | 28/10/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 4 Years |
| Upper age limit | 12 Years |
| Sex | All |
| Target sample size at registration | 103 |
| Key inclusion criteria | Children between 4 - 12 years with verruca vulgaris |
| Key exclusion criteria | 1. Immune suppression 2. Plaster allergy 3. Skin diseases in the surrounding area of the wart 4. Warts in the face or anogenital region |
| Date of first enrolment | 14/09/2005 |
| Date of final enrolment | 28/10/2005 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
University Maastricht
Maastricht
6200 MD
Netherlands
6200 MD
Netherlands
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 01/11/2006 | Yes | No |
